Is IGC (IGC) Halal?
Shariah Screening — 5 Standards
Based on financial data from March 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.9% / 30% | 1.5% / 30% | 0.3% / 30% | 25.57% / 5% | ✗ NOT HALAL |
| DJIM | 0.9% / 33% | 1.5% / 33% | 0.3% / 33% | 25.57% / 5% | ✗ NOT HALAL |
| MSCI | 2.7% / 33% | 4.6% / 33% | 0.9% / 33% | 25.57% / 5% | ✗ NOT HALAL |
| S&P | 0.9% / 33% | 1.5% / 33% | 0.3% / 33% | 25.57% / 5% | ✗ NOT HALAL |
| FTSE | 2.7% / 33% | 4.6% / 33% | 0.9% / 50% | 25.57% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 46.2% | |
| Operating Margin | -1517.8% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -83.3% | |
| Return on Assets (ROA) | -50.3% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$5M |
| Free Cash Flow | -$5M |
| Total Debt | $238,000 |
| Debt-to-Equity | 1.8 |
| Current Ratio | 1.3 |
| Total Assets | $9M |
Price & Trading
| Last Close | $0.26 |
| 50-Day MA | $0.28 |
| 200-Day MA | $0.34 |
| Avg Volume | 393K |
| Beta | 0.3 |
|
52-Week Range
$0.24
| |
About IGC (IGC)
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is IGC (IGC) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), IGC is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is IGC's debt ratio?
IGC's debt ratio is 0.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 2.7%.
What are IGC's key financial metrics?
IGC has a market capitalization of $25M, and revenue of $1M. Return on equity stands at -83.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.